BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30362868)

  • 1. Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden.
    Nugin H; Folkvaljon Y; Damber JE; Adolfsson J; Robinson D; Stattin P
    Scand J Urol; 2018 Aug; 52(4):277-284. PubMed ID: 30362868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Based Assessment of Determining Treatments for Prostate Cancer.
    Chamie K; Williams SB; Hu JC
    JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns for older veterans with localized prostate cancer.
    Hoffman RM; Shi Y; Freedland SJ; Keating NL; Walter LC
    Cancer Epidemiol; 2015 Oct; 39(5):769-77. PubMed ID: 26228494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study.
    Matta R; Hird AE; Dvorani E; Saskin R; Nason GJ; Kulkarni G; Kodama RT; Herschorn S; Nam RK
    Cancer Med; 2020 Oct; 9(19):6946-6953. PubMed ID: 32757442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden.
    George G; Garmo H; Rudman S; Holmberg L; Robinson D; Stattin P; Adolfsson J; Van Hemelrijck M
    Scand J Urol; 2020 Feb; 54(1):20-26. PubMed ID: 31842658
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
    Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
    Eur Urol; 2012 Apr; 61(4):690-700. PubMed ID: 21945719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.
    Evans SM; Millar JL; Davis ID; Murphy DG; Bolton DM; Giles GG; Frydenberg M; Andrianopoulos N; Wood JM; Frauman AG; Costello AJ; McNeil JJ
    Med J Aust; 2013 Jun; 198(10):540-5. PubMed ID: 23725268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study.
    Tomic K; Ventimiglia E; Robinson D; Häggström C; Lambe M; Stattin P
    Int J Cancer; 2018 Jun; 142(12):2478-2484. PubMed ID: 29363113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dashboard report on performance on select quality indicators to cancer care providers.
    Stattin P; Sandin F; Sandbäck T; Damber JE; Franck Lissbrant I; Robinson D; Bratt O; Lambe M
    Scand J Urol; 2016; 50(1):21-8. PubMed ID: 26162012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.
    Van Hemelrijck M; Wigertz A; Sandin F; Garmo H; Hellström K; Fransson P; Widmark A; Lambe M; Adolfsson J; Varenhorst E; Johansson JE; Stattin P;
    Int J Epidemiol; 2013 Aug; 42(4):956-67. PubMed ID: 22561842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
    Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
    Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
    Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
    Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
    Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
    Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.
    Hamilton AS; Fleming ST; Wang D; Goodman M; Wu XC; Owen JB; Lo M; Ho A; Anderson RT; Thompson T
    Am J Clin Oncol; 2016 Feb; 39(1):55-63. PubMed ID: 24390274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.
    Morgia G; Russo GI; Tubaro A; Bortolus R; Randone D; Gabriele P; Trippa F; Zattoni F; Porena M; Mirone V; Serni S; Del Nero A; Lay G; Ricardi U; Rocco F; Terrone C; Pagliarulo A; Ludovico G; Vespasiani G; Brausi M; Simeone C; Novella G; Carmignani G; Leonardi R; Pinnarò P; De Paula U; Corvò R; Tenaglia R; Siracusano S; Mantini G; Gontero P; Savoca G; Ficarra V;
    BJU Int; 2016 Jun; 117(6):867-73. PubMed ID: 26332130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.